Skip navigation

Chemical Arachidonic Acids

1–50 of 427 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 11,12-dihydroxyeicosatetraenoic acid arachidonic acid metabolic process 5-hydroxy-6,8,11,14-eicosatetraenoic acid [5-hydroxy-6,8,11,14-eicosatetraenoic acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 11,12-dihydroxyeicosatetraenoic acid 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured   1
2. 11,12-dihydroxyeicosatetraenoic acid arachidonic acid metabolic process 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid [12-Hydroxy-5,8,10,14-eicosatetraenoic Acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 11,12-dihydroxyeicosatetraenoic acid 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured   1
3. 11-oxoeicosatetraenoic acid cell proliferation 11-oxoeicosatetraenoic acid results in decreased cell proliferation 1: Homo sapiens Human Umbilical Vein Endothelial Cells   1
4. 11-oxoeicosatetraenoic acid cell proliferation 11-oxoeicosatetraenoic acid analog results in decreased cell proliferation 1: Homo sapiens Human Umbilical Vein Endothelial Cells   1
5. 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid natural killer cell mediated cytotoxicity 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid affects natural killer cell mediated cytotoxicity 1: Homo sapiens Lymphocytes   1
6. 15-hydroxy-5,8,11,13-eicosatetraenoic acid positive regulation of cardiac muscle hypertrophy 15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased positive regulation of cardiac muscle hypertrophy 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured 1 gene: PRKCA 1
7. 15-hydroxy-5,8,11,13-eicosatetraenoic acid positive regulation of NF-kappaB transcription factor activity 15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased positive regulation of NF-kappaB transcription factor activity 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
4 genes: IL1B | NFKB1 | RELA | TNF
1
8. 15-hydroxy-5,8,11,13-eicosatetraenoic acid positive regulation of ERK1 and ERK2 cascade 15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased positive regulation of ERK1 and ERK2 cascade 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
6 genes: ALOX15 | EGF | IL1B | MAPK3 | PRKCA | TNF
1
9. 15-hydroxy-5,8,11,13-eicosatetraenoic acid arachidonic acid metabolic process 15-hydroxy-5,8,11,13-eicosatetraenoic acid affects arachidonic acid metabolic process 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
3 genes: ALOX15 | ALOX5 | MAPK3
1
10. 15-hydroxy-5,8,11,13-eicosatetraenoic acid arachidonic acid metabolic process 14,15-dihydroxyeicosatrienoic acid [15-hydroxy-5,8,11,13-eicosatetraenoic acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 14,15-dihydroxyeicosatrienoic acid 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
3 genes: ALOX15 | ALOX5 | MAPK3
1
11. 15-hydroxy-5,8,11,13-eicosatetraenoic acid oocyte maturation 15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased oocyte maturation 1: Marthasterias glacialis Oocytes   1
12. 15-keto-5,8,11,13-eicosatetraenoic acid positive regulation of cellular response to oxidative stress NFE2L2 15-keto-5,8,11,13-eicosatetraenoic acid promotes the reaction [NFE2L2 protein results in increased positive regulation of cellular response to oxidative stress] 1: Homo sapiens Blood | Monocytes | Cell Line, Tumor   1
13. 15-keto-5,8,11,13-eicosatetraenoic acid positive regulation of NF-kappaB transcription factor activity TNF 15-keto-5,8,11,13-eicosatetraenoic acid inhibits the reaction [TNF protein results in increased positive regulation of NF-kappaB transcription factor activity] 1: Homo sapiens Blood | Monocytes | Cell Line, Tumor
4 genes: IKBKB | IL1B | IL6 | TNF
1
14. 15-keto-5,8,11,13-eicosatetraenoic acid positive regulation of NF-kappaB transcription factor activity Ethacrynic Acid | TNF [Ethacrynic Acid results in decreased glutathionylation of 15-keto-5,8,11,13-eicosatetraenoic acid] inhibits the reaction [TNF protein results in increased positive regulation of NF-kappaB transcription factor activity] 1: Homo sapiens Blood | Monocytes | Cell Line, Tumor
4 genes: IKBKB | IL1B | IL6 | TNF
1
15. 18-hydroxy-5,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process sodium arsenite [sodium arsenite affects arachidonic acid metabolic process] which results in decreased abundance of 18-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Mus musculus Brain   1
16. 20-carboxyleukotriene B4 regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in increased abundance of 20-carboxyleukotriene B4 1: Rattus norvegicus Serum   1
17. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasodilation 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasodilation 1: Mus musculus Basilar Artery   1
18. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasodilation Indomethacin Indomethacin inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasodilation] 1: Mus musculus Basilar Artery   1
19. 20-hydroxy-5,8,11,14-eicosatetraenoic acid regulation of blood pressure Clofibrate | Desoxycorticosterone | Sodium Chloride, Dietary [Clofibrate inhibits the reaction [[Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased regulation of blood pressure]] which results in increased abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Mus musculus Cardiovascular System 1 gene: POMC 1
20. 20-hydroxy-5,8,11,14-eicosatetraenoic acid regulation of blood pressure Sodium Chloride, Dietary 20-hydroxy-5,8,11,14-eicosatetraenoic acid affects the reaction [Sodium Chloride, Dietary affects regulation of blood pressure] 1: Rattus norvegicus Arteries 1 gene: POMC 1
21. 20-hydroxy-5,8,11,14-eicosatetraenoic acid renal sodium excretion CLOCK [CLOCK protein affects the abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] which affects renal sodium excretion 1: Mus musculus Urine   1
22. 20-hydroxy-5,8,11,14-eicosatetraenoic acid cell death 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased cell death 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
23. 20-hydroxy-5,8,11,14-eicosatetraenoic acid lactate dehydrogenase activity 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased lactate dehydrogenase activity 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
24. 20-hydroxy-5,8,11,14-eicosatetraenoic acid lactate dehydrogenase activity Cisplatin 20-hydroxy-5,8,11,14-eicosatetraenoic acid promotes the reaction [Cisplatin results in increased lactate dehydrogenase activity] 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
25. 20-hydroxy-5,8,11,14-eicosatetraenoic acid inorganic cation transmembrane transport 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in decreased inorganic cation transmembrane transport 1: Mus musculus Kidney | Epithelial Cells | Cell Line   1
26. 20-hydroxy-5,8,11,14-eicosatetraenoic acid inorganic cation transmembrane transport Rubidium [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in decreased inorganic cation transmembrane transport] which results in decreased uptake of Rubidium 1: Mus musculus Kidney | Epithelial Cells | Cell Line   1
27. 20-hydroxy-5,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process sodium arsenite [sodium arsenite affects arachidonic acid metabolic process] which results in decreased abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Mus musculus Brain
3 genes: CYP4A1 | CYP4A11 | CYP4A2
1
28. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasoconstriction 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasoconstriction 1: Mus musculus Aorta   1
29. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasoconstriction SQ 29548 SQ 29548 inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasoconstriction] 1: Mus musculus Aorta   1
30. 20-hydroxy-5,8,11,14-eicosatetraenoic acid calcium-activated potassium channel activity 20-hydroxy-5,8,11,14-eicosatetraenoic acid affects calcium-activated potassium channel activity 1: Rattus norvegicus Brain | Astrocytes | Cells, Cultured   1
31. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine [Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
32. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine results in decreased epoxygenase P450 pathway] which results in decreased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney | Blood Vessels
2 genes: CYP2C8 | CYP4A11
1
33. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Verapamil [Verapamil results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
34. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine | Verapamil Verapamil inhibits the reaction [[Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
35. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Nifedipine [Nifedipine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
36. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine | Nifedipine Nifedipine inhibits the reaction [[Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
37. 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid anoikis isoliquiritigenin 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased anoikis] 1: Homo sapiens Breast | Cell Line, Tumor 1 gene: AKT1 1
38. 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid positive regulation of vasoconstriction 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid results in increased positive regulation of vasoconstriction 1: Rattus norvegicus Kidney Glomerulus | Arterioles 1 gene: AKT1 1
39. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid results in decreased positive regulation of vasoconstriction 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
40. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 2-chloro-N(6)cyclopentyladenosine 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased positive regulation of vasoconstriction] 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
41. 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in decreased abundance of 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid 1: Rattus norvegicus Liver   1
42. 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in decreased abundance of 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid 1: Rattus norvegicus Serum   1
43. 5-hydroxy-6,8,11,14-eicosatetraenoic acid positive regulation of cardiac muscle hypertrophy 5-hydroxy-6,8,11,14-eicosatetraenoic acid results in increased positive regulation of cardiac muscle hypertrophy 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured   1
44. 5-hydroxy-6,8,11,14-eicosatetraenoic acid positive regulation of NF-kappaB transcription factor activity 5-hydroxy-6,8,11,14-eicosatetraenoic acid results in increased positive regulation of NF-kappaB transcription factor activity 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
2 genes: NFKB1 | RELA
1
45. 5-hydroxy-6,8,11,14-eicosatetraenoic acid positive regulation of ERK1 and ERK2 cascade 5-hydroxy-6,8,11,14-eicosatetraenoic acid results in increased positive regulation of ERK1 and ERK2 cascade 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured 1 gene: MAPK3 1
46. 5-hydroxy-6,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process 5-hydroxy-6,8,11,14-eicosatetraenoic acid affects arachidonic acid metabolic process 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
2 genes: ALOX5 | MAPK3
1
47. 5-hydroxy-6,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process 14,15-dihydroxyeicosatrienoic acid [5-hydroxy-6,8,11,14-eicosatetraenoic acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 14,15-dihydroxyeicosatrienoic acid 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
2 genes: ALOX5 | MAPK3
1
48. 5-hydroxy-6,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process 11,12-dihydroxyeicosatetraenoic acid [5-hydroxy-6,8,11,14-eicosatetraenoic acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 11,12-dihydroxyeicosatetraenoic acid 1: Homo sapiens Heart Ventricles | Myocytes, Cardiac | Cells, Cultured
2 genes: ALOX5 | MAPK3
1
49. 5-hydroxy-6,8,11,14-eicosatetraenoic acid regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in decreased abundance of 5-hydroxy-6,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Liver   1
50. 5-hydroxy-6,8,11,14-eicosatetraenoic acid regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in increased abundance of 5-hydroxy-6,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Serum   1
1–50 of 427 results.